|
1
|
Jain RK, di Tomaso E, Duda DG, et al:
Angiogenesis in brain tumors. Nat Rev Neurosci. 8:610–622. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ong BY, Ranganath SH, Lee LY, et al:
Paclitaxel delivery from PLGA foams for controlled release in
post-surgical chemotherapy against glioblastoma multiforme.
Biomaterials. 30:3189–3196. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wen PY and Kesari S: Malignant Gliomas in
Adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jones TS and Holland EC: Standard of care
therapy for malignant glioma and its effect on tumor and stromal
cells. Oncogene. 31:1995–2006. 2012. View Article : Google Scholar
|
|
5
|
Rich JN and Bigner DD: Development of
novel targeted therapies in the treatment of malignant glioma. Nat
Rev Drug Discov. 3:430–446. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ningaraj NS: Drug delivery to brain
tumours: challenges and progress. Expert Opin Drug Deliv.
3:499–509. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sarin H: Recent progress towards
development of effective systemic chemotherapy for the treatment of
malignant brain tumors. J Transl Med. 7:772009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xin H, Sha X, Jiang X, Zhang W, Chen L and
Fang X: Anti-glioblastoma efficacy and safety of paclitaxel-loading
Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Biomaterials. 33:8167–8176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gu G, Xia H, Hu Q, et al: PEG-co-PCL
nanoparticles modified with MMP-2/9 activatable low molecular
weight protamine for enhanced targeted glioblastoma therapy.
Biomaterials. 34:196–208. 2013. View Article : Google Scholar
|
|
10
|
Peer D, Karp JM, Hong S, Farokhzad OC,
Margalit R and Langer R: Nanocarriers as an emerging platform for
cancer therapy. Nat Nanotechnol. 2:751–760. 2007. View Article : Google Scholar
|
|
11
|
Danhier F, Le Breton AL and Préat V:
RGD-based strategies to target alpha(v) beta(3) integrin in cancer
therapy and diagnosis. Mol Pharm. 9:2961–2973. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schottelius M, Laufer B, Kessler H and
Wester HJ: Ligands for mapping alphavbeta3-integrin expression in
vivo. Acc Chem Res. 42:969–980. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen X, Park R, Shahinian AH, et al:
18F-labeled RGD peptide: initial evaluation for imaging brain tumor
angiogenesis. Nucl Med Biol. 31:179–189. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Hou Y, Tohme M, et al: Pegylated
Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor
alphavbeta3-integrin expression. J Nucl Med. 45:1776–1783.
2004.PubMed/NCBI
|
|
15
|
Gajbhiye V and Jain NK: The treatment of
Glioblastoma Xenografts by surfactant conjugated dendritic
nanoconjugates. Biomaterials. 32:6213–6225. 2011.PubMed/NCBI
|
|
16
|
Nasongkla N, Bey E, Ren J, et al:
Multifunctional polymeric micelles as cancer-targeted,
MRI-ultrasensitive drug delivery systems. Nano Lett. 6:2427–2430.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhan C, Gu B, Xie C, Li J, Liu Y and Lu W:
Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid)
micelle enhances paclitaxel anti-glioblastoma effect. J Control
Release. 143:13620–142. 2010. View Article : Google Scholar
|
|
18
|
Ramasamy T, Khandasami US, Ruttala H and
Shanmugam S: Development of solid lipid nanoparticles enriched
hydrogels for topical delivery of anti-fungal agent. Macromol Res.
20:682–692. 2012. View Article : Google Scholar
|
|
19
|
Carrion C, de Madariaga MA and Domingo JC:
In vitro cytotoxic study of immunoliposomal doxorubicin targeted to
human CD34(+) leukemic cells. Life Sci. 75:313–328. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Carvalho JC, Perazzo FF, Machado L and
Bereau D: Biologic activity and biotechnological development of
natural products. BioMed Res Int. 2013:9717452013. View Article : Google Scholar
|
|
21
|
Gupta B and Torchilin VP: Monoclonal
antibody 2C5-modified doxorubicin-loaded liposomes with
significantly enhanced therapeutic activity against intracranial
human brain U-87 MG tumor xenografts in nude mice. Cancer Immunol
Immunother. 56:1215–1223. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J and Shapiro JI: Endocytosis and
signal transduction: basic science update. Biol Res Nurs.
5:117–128. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang X, Sha X, Xin H, et al:
Self-aggregated pegylated poly (trimethylene carbonate)
nanoparticles decorated with c(RGDyK) peptide for targeted
paclitaxel delivery to integrin-rich tumors. Biomaterials.
32:9457–9469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang X, Sha X, Xin H, et al:
Integrin-facilitated transcytosis for enhanced penetration of
advanced gliomas by poly(trimethylene carbonate)-based
nanoparticles encapsulating paclitaxel. Biomaterials. 34:2969–2979.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Downing KH and Nogales E: Tubulin and
microtubule structure. Curr Opin Cell Biol. 10:16–22. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miller ML and Ojima I: Chemistry and
chemical biology of taxane anticancer agents. Chem Rec. 1:195–211.
2001. View
Article : Google Scholar
|
|
27
|
Gao H, Yang Z, Zhang S, et al:
Glioma-homing peptide with a cell-penetrating effect for targeting
delivery with enhanced glioma localization, penetration and
suppression of glioma growth. J Control Release. 172:921–928. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kanazawa T, Taki H, Tanaka K, Takashima Y
and Okada H: Cell-penetrating peptide-modified block copolymer
micelles promote direct brain delivery via intranasal
administration. Pharm Res. 28:2130–2139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao H, Wang JC, Sun QS, et al: RGD-based
strategies for improving antitumor activity of paclitaxel-loaded
liposomes in nude mice xenografted with human ovarian cancer. J
Drug Target. 17:10–18. 2009. View Article : Google Scholar
|
|
30
|
Saad M, Garbuzenko OB, Ber E, et al:
Receptor targeted polymers, dendrimers, liposomes: which
nanocarrier is the most efficient for tumor-specific treatment and
imaging? J Control Release. 130:107–114. 2008. View Article : Google Scholar : PubMed/NCBI
|
